Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | ||||||
{[ item.p_purity ]} | {[ item.pr_size ]} | Inquiry |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price) ]} |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price) ]} | {[ item.pr_usastock ]} | in stock Inquiry - | {[ item.pr_chinastock ]} | {[ item.pr_remark ]} in stock Inquiry - | Login | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
The evaluation of isatin analogues as inhibitors of monoamine oxidase
Prinsloo, Izak F. ; Petzer, Jacobus P. ; Cloete, Theunis T. , et al. Chem. Biol. Drug Des.,2023,102(5):1067-1074. DOI: 10.1111/cbdd.14304 PubMed ID: 37500571
More
Abstract: The small mol., isatin, is a well-known reversible inhibitor of the monoamine oxidase (MAO) enzymes with IC50 values of 12.3 and 4.86μM for MAO-A and MAO-B, resp. While the interaction of isatin with MAO-B has been characterized, only a few studies have explored structure-activity relationships (SARs) of MAO inhibition by isatin analogs. The current study therefore evaluated a series of 14 isatin analogs as in vitro inhibitors of human MAO-A and MAO-B. The results indicated good potency MAO inhibition for some isatin analogs with five compounds exhibiting IC50 < 1μM. 4-Chloroisatin (1b) and 5-bromoisatin (1f) were the most potent inhibitors with IC50 values of 0.812 and 0.125μM for MAO-A and MAO-B, resp. These compounds were also found to be competitive inhibitors of MAO-A and MAO-B with Ki values of 0.311 and 0.033μM, resp. Among the SARs, it was interesting to note that C5-substitution was particularly beneficial for MAO-B inhibition. MAO inhibitors are established drugs for the treatment of neuropsychiatric and neurodegenerative disorders, while potential new roles in prostate cancer and cardiovascular disease are being investigated.
Keywords: competitive ; inhibition ; isatin ; monoamine oxidase ; structure-activity relationship
Purchased from AmBeed: 6341-92-0 ; 91-56-5 ; 1127-59-9 ; 611-09-6 ; 7477-63-6 ; 6344-05-4 ; 443-69-6 ; 87-48-9 ; 39603-24-2 ; 608-05-9 ; 17630-76-1 ; 20205-43-0 ; 131609-60-4 ; 150560-58-0 ; 57816-97-4 ...More
CAS No. : | 6344-05-4 | MDL No. : | MFCD00129178 |
Formula : | C8H4ClNO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | HSYFISNDMZKGRS-UHFFFAOYSA-N |
M.W : | 181.58 | Pubchem ID : | 96047 |
Synonyms : |
|
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319 | Packing Group: | N/A |
GHS Pictogram: |
[ 18711-13-2 ]
4,7-Dichloroindoline-2,3-dione
Similarity: 0.95
[ 1677-48-1 ]
5,6-Dichloroindoline-2,3-dione
Similarity: 0.89
[ 18711-13-2 ]
4,7-Dichloroindoline-2,3-dione
Similarity: 0.95
[ 1677-48-1 ]
5,6-Dichloroindoline-2,3-dione
Similarity: 0.89
[ 18711-13-2 ]
4,7-Dichloroindoline-2,3-dione
Similarity: 0.95
[ 1677-48-1 ]
5,6-Dichloroindoline-2,3-dione
Similarity: 0.89
[ 18711-13-2 ]
4,7-Dichloroindoline-2,3-dione
Similarity: 0.95
[ 1677-48-1 ]
5,6-Dichloroindoline-2,3-dione
Similarity: 0.89